SCHEMBL30689366

SCHEMBL30689366

C=C(Cc1nc(-c2ccc(Oc3ccc(C(F)(F)F)nc3)cc2)no1)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN9A Q15858 3/20 0.44
▸ FPR2 P25090 1/20 0.44
▸ FFAR1 O14842 2/20 0.44
▸ GSTP1 P09211 4/20 0.42
▸ TP53 P04637 2/20 0.41
▸ MITF O75030 1/20 0.41
▸ NCOA3 Q9Y6Q9 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ ATM Q13315 1/20 0.40
▸ ACACB O00763 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ PLAAT3 P53816 1/20 0.39
▸ PLAAT5 Q96KN8 1/20 0.39
▸ PLAAT2 Q9NWW9 1/20 0.39
▸ PLAAT4 Q9UL19 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689345 0.89 FFAR1 (0.45) FFAR1GSTP1TP53MITFNCOA3
SCHEMBL30689328 0.88 FFAR1 (0.43) SCN9AFFAR1GSTP1TP53MITF
SCHEMBL30689333 0.86 GSTP1 (0.43) FFAR1GSTP1TP53MITFNCOA3
SCHEMBL30689351 0.85 FFAR1 (0.41) FFAR1GSTP1TP53MITFNCOA3
SCHEMBL30689340 0.84 GSTP1 (0.41) FFAR1GSTP1TP53MITFNCOA3
SCHEMBL30689419 0.83 FFAR1 (0.53) FFAR1GSTP1TP53MITFNCOA3
SCHEMBL30689302 0.82 FFAR1 (0.49) SCN9AFPR2FFAR1GSTP1TP53
SCHEMBL30689300 0.82 GSTP1 (0.45) FFAR1GSTP1TP53LMNAATM
SCHEMBL31527955 0.81 LMNA (0.46) TP53MITFNCOA3LMNAATM
SCHEMBL31527948 0.81 PSMB5 (0.49) TP53LMNAATMACACBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO disclosed
Send feedback